Mira Thing
Hvidovre, 2650, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Investigation of non-invasive tests for fibrosis diagnosis and prognostication of events in metabolic dysfunction-associated steatotic liver disease: A prospective study cohort.
Journal: Annals of hepatology
Published: February 27, 2026
Magnetic resonance imaging-derived extracellular volume fraction mapping in metabolic dysfunction-associated steatotic liver disease reveals subclinical cardiac remodelling.
Journal: Scientific reports
Published: January 08, 2026
Decoding fibrosis: Transcriptomic and clinical insights via AI-derived collagen deposition phenotypes in MASLD.
Journal: Hepatology (Baltimore, Md.)
Published: September 24, 2025
Diagnostics of Autoimmune Hepatitis Enabled by Non-Invasive Clinical Proteomics.
Journal: Alimentary pharmacology & therapeutics
Published: March 07, 2025
Alterations in one-carbon metabolism in metabolic dysfunction associated steatotic liver disease may be modified by semaglutide.
Journal: Annals of hepatology
Published: January 02, 2025
Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: August 06, 2024
Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: April 16, 2024
Glucagon Clearance Is Decreased in Chronic Kidney Disease but Preserved in Liver Cirrhosis.
Journal: Diabetes
Published: April 09, 2024
Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population.
Journal: Clinics and research in hepatology and gastroenterology
Published: February 21, 2024
Circulating and hepatic levels of growth differentiation factor 15 in patients with metabolic dysfunction-associated steatotic liver disease.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: January 11, 2024
Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease.
Journal: BMC gastroenterology
Published: November 08, 2023
Children with bone and joint infections had no pathogens or resistance patterns requiring broad-spectrum antibiotics.
Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: July 09, 2023
Last Updated: 09/26/2026